Please note that slides are for review only and not to be repurposed or published.

Beyond the Guidelines: Investigator Perspectives on Current Clinical Issues and Ongoing Research in the Systemic Treatment of Prostate Cancer

Introduction:
Dr Love

MODULE 1:
Existing and Emerging Therapeutic Strategies for the Management of M0 Prostate Cancer (PC) — Dr Petrylak

MODULE 2:
Management of Hormone-Sensitive Metastatic PC — Dr Fizazi

MODULE 3:
Clinical Algorithms for Patients with Metastatic CRPC — Dr Taplin

MODULE 4:
Bone-Targeted Therapies and Other Emerging Radiopharmaceuticals — Dr Sartor

MODULE 5:
Other Promising Novel Agents and Strategies Under Investigation — Dr Dreicer

Live Poll Results
Download

Cases from the Community: Clinical Investigators Provide Their Perspectives on the Use of Immune Checkpoint Inhibitors in the Management of Actual Patients with Genitourinary Cancers

Introduction:
Dr Love

MODULE 1:
Current and Future Integration of Immune Checkpoint Inhibitors into the Management of Urothelial Bladder Cancer (UBC) — Dr O’Donnell

MODULE 2:
Existing and Emerging Role of Anti-PD-1/PD-L1 Antibodies in Renal Cell Carcinoma (RCC) — Dr Powles

MODULE 3:
Clinical Trials of Immune Checkpoint Inhibition in Prostate Cancer — Dr Quinn

MODULE 4:
Patterns and Predictors of Response to Immune Checkpoint Inhibitors — Dr Drake

MODULE 5:
Incidence and Management of Toxicities Associated with Immune Checkpoint Inhibitors; Autoimmune Contraindications to Treatment — Dr Plimack

Live Poll Results
Download